DSM finalises Pentapharm acquisition

Published: 30-Aug-2007

Pentapharm and DSM have now now signed the official contracts agreeing the 100% transference of Pentapharm's shares to DSM.

Pentapharm and DSM have now now signed the official contracts agreeing the 100% transference of Pentapharm's shares to DSM.

Caspar Stürm, the privatey owned Pentapharm's ceo for nearly 25 years, has passed ownership of the company to DSM where Ute Schick, director of DSM nutritional products new business development - personal care, will succeed him.

DSM says its goal is to create a leading global supplier of cosmetic active ingredients by combining DSM's capabilities in terms of claim substantiation, test design and regulatory environment with Pentapharm's track record in positioning and introduction of innovative products.

You may also like